nodes	percent_of_prediction	percent_of_DWPC	metapath
Trandolapril—CES1—Irinotecan—lung cancer	0.409	1	CbGbCtD
Trandolapril—ACE—pulmonary artery—lung cancer	0.0198	0.268	CbGeAlD
Trandolapril—ACE—umbilical vein—lung cancer	0.0131	0.177	CbGeAlD
Trandolapril—CES1—Irinotecan Pathway—UGT1A1—lung cancer	0.00508	0.078	CbGpPWpGaD
Trandolapril—CES1—respiratory system—lung cancer	0.00501	0.0677	CbGeAlD
Trandolapril—CES1—Irinotecan Pathway—ABCG2—lung cancer	0.0044	0.0676	CbGpPWpGaD
Trandolapril—SLC15A2—mammary gland—lung cancer	0.00436	0.0589	CbGeAlD
Trandolapril—SLC15A1—epithelium—lung cancer	0.00389	0.0525	CbGeAlD
Trandolapril—ACE—respiratory system—lung cancer	0.00333	0.045	CbGeAlD
Trandolapril—CES1—Fluoropyrimidine Activity—RRM1—lung cancer	0.0032	0.0491	CbGpPWpGaD
Trandolapril—SLC15A2—respiratory system—lung cancer	0.00291	0.0393	CbGeAlD
Trandolapril—ACE—epithelium—lung cancer	0.00279	0.0376	CbGeAlD
Trandolapril—CES1—Fluoropyrimidine Activity—ABCC3—lung cancer	0.00272	0.0418	CbGpPWpGaD
Trandolapril—CES1—lung—lung cancer	0.00266	0.0359	CbGeAlD
Trandolapril—SLC15A2—bronchus—lung cancer	0.00239	0.0323	CbGeAlD
Trandolapril—ACE—cardiac atrium—lung cancer	0.00231	0.0312	CbGeAlD
Trandolapril—ACE—Peptide hormone metabolism—KIF5B—lung cancer	0.00224	0.0344	CbGpPWpGaD
Trandolapril—CES1—Fluoropyrimidine Activity—ABCG2—lung cancer	0.00222	0.0341	CbGpPWpGaD
Trandolapril—SLC15A2—trachea—lung cancer	0.00215	0.029	CbGeAlD
Trandolapril—CES1—Fluoropyrimidine Activity—CYP2A6—lung cancer	0.00208	0.032	CbGpPWpGaD
Trandolapril—CES1—Irinotecan Pathway—APC—lung cancer	0.00198	0.0304	CbGpPWpGaD
Trandolapril—ACE—bone marrow—lung cancer	0.00195	0.0264	CbGeAlD
Trandolapril—CES1—lymph node—lung cancer	0.00182	0.0246	CbGeAlD
Trandolapril—ACE—lung—lung cancer	0.00177	0.0239	CbGeAlD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A2—lung cancer	0.00175	0.0269	CbGpPWpGaD
Trandolapril—CES1—Fluoropyrimidine Activity—SMUG1—lung cancer	0.0017	0.0261	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—RRM1—lung cancer	0.00169	0.026	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—MCL1—lung cancer	0.00169	0.026	CbGpPWpGaD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A2—lung cancer	0.00163	0.025	CbGpPWpGaD
Trandolapril—SLC15A2—lung—lung cancer	0.00154	0.0208	CbGeAlD
Trandolapril—CES1—E2F transcription factor network—XRCC1—lung cancer	0.00138	0.0212	CbGpPWpGaD
Trandolapril—CES1—Fluoropyrimidine Activity—TYMS—lung cancer	0.00136	0.0209	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—GRP—lung cancer	0.00135	0.0207	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—PRDX1—lung cancer	0.00128	0.0197	CbGpPWpGaD
Trandolapril—CES1—Fluoropyrimidine Activity—ERCC2—lung cancer	0.00126	0.0194	CbGpPWpGaD
Trandolapril—ACE—lymph node—lung cancer	0.00121	0.0163	CbGeAlD
Trandolapril—CES1—NRF2 pathway—GSTM2—lung cancer	0.00121	0.0185	CbGpPWpGaD
Trandolapril—SLC15A2—lymph node—lung cancer	0.00106	0.0143	CbGeAlD
Trandolapril—CES1—NRF2 pathway—GSTA3—lung cancer	0.000973	0.0149	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—KEAP1—lung cancer	0.000915	0.0141	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—GSTA4—lung cancer	0.00089	0.0137	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—GSTA2—lung cancer	0.000867	0.0133	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—GSTA1—lung cancer	0.000837	0.0129	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—ABCC3—lung cancer	0.000827	0.0127	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC34A2—lung cancer	0.000784	0.012	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—UGT1A1—lung cancer	0.000778	0.012	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—NFE2L2—lung cancer	0.000737	0.0113	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC34A2—lung cancer	0.000727	0.0112	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—TYMS—lung cancer	0.00072	0.0111	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—TGFA—lung cancer	0.000703	0.0108	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—GCLC—lung cancer	0.000634	0.00974	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—CYP2A6—lung cancer	0.000634	0.00974	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.000594	0.00912	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.000551	0.00847	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—EIF2B4—lung cancer	0.000539	0.00828	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—NQO1—lung cancer	0.000533	0.00819	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—CREBBP—lung cancer	0.00049	0.00753	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—RB1—lung cancer	0.000488	0.0075	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—POMC—lung cancer	0.000487	0.00748	CbGpPWpGaD
Trandolapril—CES1—Fluoropyrimidine Activity—TP53—lung cancer	0.00045	0.00692	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—GSTP1—lung cancer	0.000445	0.00683	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—KHSRP—lung cancer	0.000439	0.00675	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—CDKN2A—lung cancer	0.000429	0.00659	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—KIF5B—lung cancer	0.000423	0.0065	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—GSTM1—lung cancer	0.000409	0.00628	CbGpPWpGaD
Trandolapril—Perindopril—ABCB1—lung cancer	0.000408	0.258	CrCbGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.000398	0.00612	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—EIF2B5—lung cancer	0.000384	0.0059	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.00037	0.00568	CbGpPWpGaD
Trandolapril—Lisinopril—ABCB1—lung cancer	0.00036	0.228	CrCbGaD
Trandolapril—Cilazapril—ABCB1—lung cancer	0.00036	0.228	CrCbGaD
Trandolapril—CES1—E2F transcription factor network—CDKN1A—lung cancer	0.000351	0.00539	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—EP300—lung cancer	0.000334	0.00513	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—ST3GAL5—lung cancer	0.000327	0.00502	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000302	0.00464	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—ADAMTS1—lung cancer	0.000291	0.00447	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—B4GALT5—lung cancer	0.000291	0.00447	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—MYC—lung cancer	0.000291	0.00447	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.00028	0.0043	CbGpPWpGaD
Trandolapril—Enalapril—ABCB1—lung cancer	0.000264	0.167	CrCbGaD
Trandolapril—ACE—Metabolism of proteins—GRP—lung cancer	0.000255	0.00392	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—ATF3—lung cancer	0.000222	0.00341	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—LMNA—lung cancer	0.000199	0.00307	CbGpPWpGaD
Trandolapril—Nateglinide—ALB—lung cancer	0.000189	0.12	CrCbGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—AVP—lung cancer	0.000187	0.00287	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000181	0.00278	CbGpPWpGaD
Trandolapril—Pancytopenia—Doxorubicin—lung cancer	0.000175	0.000389	CcSEcCtD
Trandolapril—Nausea—Vinorelbine—lung cancer	0.000175	0.000388	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Etoposide—lung cancer	0.000174	0.000387	CcSEcCtD
Trandolapril—Dyspepsia—Paclitaxel—lung cancer	0.000174	0.000387	CcSEcCtD
Trandolapril—Body temperature increased—Cisplatin—lung cancer	0.000174	0.000387	CcSEcCtD
Trandolapril—Asthenia—Irinotecan—lung cancer	0.000174	0.000387	CcSEcCtD
Trandolapril—Fatigue—Etoposide—lung cancer	0.000174	0.000387	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000174	0.000386	CcSEcCtD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—AVP—lung cancer	0.000173	0.00267	CbGpPWpGaD
Trandolapril—Constipation—Etoposide—lung cancer	0.000173	0.000384	CcSEcCtD
Trandolapril—Neutropenia—Doxorubicin—lung cancer	0.000172	0.000383	CcSEcCtD
Trandolapril—Decreased appetite—Paclitaxel—lung cancer	0.000172	0.000382	CcSEcCtD
Trandolapril—Dry mouth—Docetaxel—lung cancer	0.000171	0.00038	CcSEcCtD
Trandolapril—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000171	0.00038	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000171	0.00038	CcSEcCtD
Trandolapril—Fatigue—Paclitaxel—lung cancer	0.000171	0.000379	CcSEcCtD
Trandolapril—Hepatitis—Methotrexate—lung cancer	0.00017	0.000378	CcSEcCtD
Trandolapril—Pollakiuria—Doxorubicin—lung cancer	0.00017	0.000378	CcSEcCtD
Trandolapril—Asthenia—Gemcitabine—lung cancer	0.00017	0.000377	CcSEcCtD
Trandolapril—Constipation—Paclitaxel—lung cancer	0.000169	0.000376	CcSEcCtD
Trandolapril—Pharyngitis—Methotrexate—lung cancer	0.000169	0.000375	CcSEcCtD
Trandolapril—Urinary tract disorder—Methotrexate—lung cancer	0.000168	0.000373	CcSEcCtD
Trandolapril—Photosensitivity reaction—Doxorubicin—lung cancer	0.000168	0.000373	CcSEcCtD
Trandolapril—Oedema—Docetaxel—lung cancer	0.000168	0.000373	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000168	0.00258	CbGpPWpGaD
Trandolapril—Pruritus—Gemcitabine—lung cancer	0.000167	0.000372	CcSEcCtD
Trandolapril—Urethral disorder—Methotrexate—lung cancer	0.000167	0.000371	CcSEcCtD
Trandolapril—Infection—Docetaxel—lung cancer	0.000167	0.00037	CcSEcCtD
Trandolapril—Feeling abnormal—Etoposide—lung cancer	0.000167	0.00037	CcSEcCtD
Trandolapril—Hyperglycaemia—Doxorubicin—lung cancer	0.000166	0.000369	CcSEcCtD
Trandolapril—Diarrhoea—Irinotecan—lung cancer	0.000166	0.000369	CcSEcCtD
Trandolapril—Gastrointestinal pain—Etoposide—lung cancer	0.000165	0.000367	CcSEcCtD
Trandolapril—Shock—Docetaxel—lung cancer	0.000165	0.000367	CcSEcCtD
Trandolapril—Nervous system disorder—Docetaxel—lung cancer	0.000165	0.000366	CcSEcCtD
Trandolapril—Thrombocytopenia—Docetaxel—lung cancer	0.000164	0.000365	CcSEcCtD
Trandolapril—Infestation NOS—Doxorubicin—lung cancer	0.000164	0.000365	CcSEcCtD
Trandolapril—Drowsiness—Doxorubicin—lung cancer	0.000164	0.000365	CcSEcCtD
Trandolapril—Infestation—Doxorubicin—lung cancer	0.000164	0.000365	CcSEcCtD
Trandolapril—Visual impairment—Methotrexate—lung cancer	0.000164	0.000364	CcSEcCtD
Trandolapril—Tachycardia—Docetaxel—lung cancer	0.000164	0.000364	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—GNG11—lung cancer	0.000164	0.00252	CbGpPWpGaD
Trandolapril—Feeling abnormal—Paclitaxel—lung cancer	0.000163	0.000362	CcSEcCtD
Trandolapril—Skin disorder—Docetaxel—lung cancer	0.000163	0.000362	CcSEcCtD
Trandolapril—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000163	0.000362	CcSEcCtD
Trandolapril—Hypersensitivity—Cisplatin—lung cancer	0.000163	0.000361	CcSEcCtD
Trandolapril—Gastrointestinal pain—Paclitaxel—lung cancer	0.000162	0.00036	CcSEcCtD
Trandolapril—Diarrhoea—Gemcitabine—lung cancer	0.000162	0.000359	CcSEcCtD
Trandolapril—Renal failure—Doxorubicin—lung cancer	0.000162	0.000359	CcSEcCtD
Trandolapril—Erythema multiforme—Methotrexate—lung cancer	0.000161	0.000358	CcSEcCtD
Trandolapril—Dizziness—Irinotecan—lung cancer	0.000161	0.000357	CcSEcCtD
Trandolapril—Urticaria—Etoposide—lung cancer	0.000161	0.000356	CcSEcCtD
Trandolapril—Anorexia—Docetaxel—lung cancer	0.00016	0.000355	CcSEcCtD
Trandolapril—Body temperature increased—Etoposide—lung cancer	0.00016	0.000355	CcSEcCtD
Trandolapril—Abdominal pain—Etoposide—lung cancer	0.00016	0.000355	CcSEcCtD
Trandolapril—Urinary tract infection—Doxorubicin—lung cancer	0.00016	0.000355	CcSEcCtD
Trandolapril—Eye disorder—Methotrexate—lung cancer	0.000159	0.000353	CcSEcCtD
Trandolapril—Tinnitus—Methotrexate—lung cancer	0.000159	0.000353	CcSEcCtD
Trandolapril—Asthenia—Cisplatin—lung cancer	0.000158	0.000351	CcSEcCtD
Trandolapril—Cardiac disorder—Methotrexate—lung cancer	0.000158	0.000351	CcSEcCtD
Trandolapril—Sweating—Doxorubicin—lung cancer	0.000158	0.00035	CcSEcCtD
Trandolapril—Urticaria—Paclitaxel—lung cancer	0.000157	0.000349	CcSEcCtD
Trandolapril—Hypotension—Docetaxel—lung cancer	0.000157	0.000348	CcSEcCtD
Trandolapril—Abdominal pain—Paclitaxel—lung cancer	0.000157	0.000348	CcSEcCtD
Trandolapril—Body temperature increased—Paclitaxel—lung cancer	0.000157	0.000348	CcSEcCtD
Trandolapril—Hepatobiliary disease—Doxorubicin—lung cancer	0.000155	0.000345	CcSEcCtD
Trandolapril—Epistaxis—Doxorubicin—lung cancer	0.000155	0.000344	CcSEcCtD
Trandolapril—Angiopathy—Methotrexate—lung cancer	0.000155	0.000343	CcSEcCtD
Trandolapril—Vomiting—Irinotecan—lung cancer	0.000154	0.000343	CcSEcCtD
Trandolapril—Immune system disorder—Methotrexate—lung cancer	0.000154	0.000342	CcSEcCtD
Trandolapril—Mediastinal disorder—Methotrexate—lung cancer	0.000154	0.000341	CcSEcCtD
Trandolapril—Agranulocytosis—Doxorubicin—lung cancer	0.000153	0.00034	CcSEcCtD
Trandolapril—Rash—Irinotecan—lung cancer	0.000153	0.00034	CcSEcCtD
Trandolapril—Dermatitis—Irinotecan—lung cancer	0.000153	0.00034	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000153	0.00034	CcSEcCtD
Trandolapril—Headache—Irinotecan—lung cancer	0.000152	0.000338	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—GNG11—lung cancer	0.000152	0.00234	CbGpPWpGaD
Trandolapril—Insomnia—Docetaxel—lung cancer	0.000152	0.000337	CcSEcCtD
Trandolapril—Diarrhoea—Cisplatin—lung cancer	0.000151	0.000335	CcSEcCtD
Trandolapril—Paraesthesia—Docetaxel—lung cancer	0.000151	0.000335	CcSEcCtD
Trandolapril—Alopecia—Methotrexate—lung cancer	0.000151	0.000334	CcSEcCtD
Trandolapril—Vomiting—Gemcitabine—lung cancer	0.00015	0.000334	CcSEcCtD
Trandolapril—Bradycardia—Doxorubicin—lung cancer	0.00015	0.000333	CcSEcCtD
Trandolapril—Dyspnoea—Docetaxel—lung cancer	0.00015	0.000332	CcSEcCtD
Trandolapril—Somnolence—Docetaxel—lung cancer	0.000149	0.000331	CcSEcCtD
Trandolapril—Mental disorder—Methotrexate—lung cancer	0.000149	0.000331	CcSEcCtD
Trandolapril—Rash—Gemcitabine—lung cancer	0.000149	0.000331	CcSEcCtD
Trandolapril—Dermatitis—Gemcitabine—lung cancer	0.000149	0.000331	CcSEcCtD
Trandolapril—Hypersensitivity—Etoposide—lung cancer	0.000149	0.00033	CcSEcCtD
Trandolapril—Malnutrition—Methotrexate—lung cancer	0.000148	0.000329	CcSEcCtD
Trandolapril—Headache—Gemcitabine—lung cancer	0.000148	0.000329	CcSEcCtD
Trandolapril—Rhinitis—Doxorubicin—lung cancer	0.000148	0.000328	CcSEcCtD
Trandolapril—Dyspepsia—Docetaxel—lung cancer	0.000148	0.000328	CcSEcCtD
Trandolapril—Hepatitis—Doxorubicin—lung cancer	0.000148	0.000327	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000147	0.00226	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000147	0.00226	CbGpPWpGaD
Trandolapril—Pharyngitis—Doxorubicin—lung cancer	0.000146	0.000325	CcSEcCtD
Trandolapril—Decreased appetite—Docetaxel—lung cancer	0.000146	0.000324	CcSEcCtD
Trandolapril—Hypersensitivity—Paclitaxel—lung cancer	0.000146	0.000324	CcSEcCtD
Trandolapril—Urinary tract disorder—Doxorubicin—lung cancer	0.000146	0.000323	CcSEcCtD
Trandolapril—Oedema peripheral—Doxorubicin—lung cancer	0.000145	0.000323	CcSEcCtD
Trandolapril—Dysgeusia—Methotrexate—lung cancer	0.000145	0.000322	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Docetaxel—lung cancer	0.000145	0.000322	CcSEcCtD
Trandolapril—Asthenia—Etoposide—lung cancer	0.000145	0.000322	CcSEcCtD
Trandolapril—Connective tissue disorder—Doxorubicin—lung cancer	0.000145	0.000322	CcSEcCtD
Trandolapril—Fatigue—Docetaxel—lung cancer	0.000145	0.000321	CcSEcCtD
Trandolapril—Urethral disorder—Doxorubicin—lung cancer	0.000145	0.000321	CcSEcCtD
Trandolapril—Nausea—Irinotecan—lung cancer	0.000144	0.00032	CcSEcCtD
Trandolapril—Constipation—Docetaxel—lung cancer	0.000144	0.000319	CcSEcCtD
Trandolapril—Back pain—Methotrexate—lung cancer	0.000143	0.000318	CcSEcCtD
Trandolapril—Pruritus—Etoposide—lung cancer	0.000143	0.000317	CcSEcCtD
Trandolapril—Visual impairment—Doxorubicin—lung cancer	0.000142	0.000316	CcSEcCtD
Trandolapril—Asthenia—Paclitaxel—lung cancer	0.000142	0.000316	CcSEcCtD
Trandolapril—Nausea—Gemcitabine—lung cancer	0.000141	0.000312	CcSEcCtD
Trandolapril—Vomiting—Cisplatin—lung cancer	0.00014	0.000311	CcSEcCtD
Trandolapril—Pruritus—Paclitaxel—lung cancer	0.00014	0.000311	CcSEcCtD
Trandolapril—Erythema multiforme—Doxorubicin—lung cancer	0.000139	0.00031	CcSEcCtD
Trandolapril—Rash—Cisplatin—lung cancer	0.000139	0.000309	CcSEcCtD
Trandolapril—Dermatitis—Cisplatin—lung cancer	0.000139	0.000308	CcSEcCtD
Trandolapril—Feeling abnormal—Docetaxel—lung cancer	0.000138	0.000307	CcSEcCtD
Trandolapril—Diarrhoea—Etoposide—lung cancer	0.000138	0.000307	CcSEcCtD
Trandolapril—Eye disorder—Doxorubicin—lung cancer	0.000138	0.000306	CcSEcCtD
Trandolapril—Ill-defined disorder—Methotrexate—lung cancer	0.000138	0.000305	CcSEcCtD
Trandolapril—Tinnitus—Doxorubicin—lung cancer	0.000138	0.000305	CcSEcCtD
Trandolapril—Gastrointestinal pain—Docetaxel—lung cancer	0.000137	0.000305	CcSEcCtD
Trandolapril—Anaemia—Methotrexate—lung cancer	0.000137	0.000304	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—TF—lung cancer	0.000137	0.00211	CbGpPWpGaD
Trandolapril—Flushing—Doxorubicin—lung cancer	0.000137	0.000304	CcSEcCtD
Trandolapril—Cardiac disorder—Doxorubicin—lung cancer	0.000137	0.000304	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000137	0.0021	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000137	0.0021	CbGpPWpGaD
Trandolapril—Diarrhoea—Paclitaxel—lung cancer	0.000136	0.000301	CcSEcCtD
Trandolapril—Angiopathy—Doxorubicin—lung cancer	0.000134	0.000297	CcSEcCtD
Trandolapril—Malaise—Methotrexate—lung cancer	0.000134	0.000297	CcSEcCtD
Trandolapril—Dizziness—Etoposide—lung cancer	0.000134	0.000297	CcSEcCtD
Trandolapril—Immune system disorder—Doxorubicin—lung cancer	0.000133	0.000296	CcSEcCtD
Trandolapril—Vertigo—Methotrexate—lung cancer	0.000133	0.000296	CcSEcCtD
Trandolapril—Mediastinal disorder—Doxorubicin—lung cancer	0.000133	0.000295	CcSEcCtD
Trandolapril—Body temperature increased—Docetaxel—lung cancer	0.000133	0.000295	CcSEcCtD
Trandolapril—Abdominal pain—Docetaxel—lung cancer	0.000133	0.000295	CcSEcCtD
Trandolapril—Leukopenia—Methotrexate—lung cancer	0.000133	0.000295	CcSEcCtD
Trandolapril—Arrhythmia—Doxorubicin—lung cancer	0.000132	0.000293	CcSEcCtD
Trandolapril—Dizziness—Paclitaxel—lung cancer	0.000131	0.000291	CcSEcCtD
Trandolapril—Nausea—Cisplatin—lung cancer	0.000131	0.000291	CcSEcCtD
Trandolapril—Alopecia—Doxorubicin—lung cancer	0.00013	0.000289	CcSEcCtD
Trandolapril—Cough—Methotrexate—lung cancer	0.000129	0.000287	CcSEcCtD
Trandolapril—Mental disorder—Doxorubicin—lung cancer	0.000129	0.000287	CcSEcCtD
Trandolapril—Vomiting—Etoposide—lung cancer	0.000128	0.000285	CcSEcCtD
Trandolapril—Malnutrition—Doxorubicin—lung cancer	0.000128	0.000285	CcSEcCtD
Trandolapril—Rash—Etoposide—lung cancer	0.000127	0.000283	CcSEcCtD
Trandolapril—Dermatitis—Etoposide—lung cancer	0.000127	0.000283	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—TF—lung cancer	0.000127	0.00195	CbGpPWpGaD
Trandolapril—Headache—Etoposide—lung cancer	0.000127	0.000281	CcSEcCtD
Trandolapril—Flatulence—Doxorubicin—lung cancer	0.000127	0.000281	CcSEcCtD
Trandolapril—Arthralgia—Methotrexate—lung cancer	0.000126	0.00028	CcSEcCtD
Trandolapril—Chest pain—Methotrexate—lung cancer	0.000126	0.00028	CcSEcCtD
Trandolapril—Myalgia—Methotrexate—lung cancer	0.000126	0.00028	CcSEcCtD
Trandolapril—Vomiting—Paclitaxel—lung cancer	0.000126	0.00028	CcSEcCtD
Trandolapril—Dysgeusia—Doxorubicin—lung cancer	0.000126	0.000279	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000125	0.000278	CcSEcCtD
Trandolapril—Rash—Paclitaxel—lung cancer	0.000125	0.000277	CcSEcCtD
Trandolapril—Dermatitis—Paclitaxel—lung cancer	0.000125	0.000277	CcSEcCtD
Trandolapril—Discomfort—Methotrexate—lung cancer	0.000125	0.000277	CcSEcCtD
Trandolapril—Back pain—Doxorubicin—lung cancer	0.000124	0.000276	CcSEcCtD
Trandolapril—Headache—Paclitaxel—lung cancer	0.000124	0.000276	CcSEcCtD
Trandolapril—Hypersensitivity—Docetaxel—lung cancer	0.000124	0.000275	CcSEcCtD
Trandolapril—Muscle spasms—Doxorubicin—lung cancer	0.000123	0.000274	CcSEcCtD
Trandolapril—Asthenia—Docetaxel—lung cancer	0.000121	0.000267	CcSEcCtD
Trandolapril—Infection—Methotrexate—lung cancer	0.00012	0.000267	CcSEcCtD
Trandolapril—Nausea—Etoposide—lung cancer	0.00012	0.000266	CcSEcCtD
Trandolapril—Ill-defined disorder—Doxorubicin—lung cancer	0.000119	0.000264	CcSEcCtD
Trandolapril—Pruritus—Docetaxel—lung cancer	0.000119	0.000264	CcSEcCtD
Trandolapril—Nervous system disorder—Methotrexate—lung cancer	0.000119	0.000263	CcSEcCtD
Trandolapril—Anaemia—Doxorubicin—lung cancer	0.000119	0.000263	CcSEcCtD
Trandolapril—Thrombocytopenia—Methotrexate—lung cancer	0.000119	0.000263	CcSEcCtD
Trandolapril—Agitation—Doxorubicin—lung cancer	0.000118	0.000262	CcSEcCtD
Trandolapril—Nausea—Paclitaxel—lung cancer	0.000118	0.000261	CcSEcCtD
Trandolapril—Skin disorder—Methotrexate—lung cancer	0.000118	0.000261	CcSEcCtD
Trandolapril—Hyperhidrosis—Methotrexate—lung cancer	0.000117	0.00026	CcSEcCtD
Trandolapril—Malaise—Doxorubicin—lung cancer	0.000116	0.000257	CcSEcCtD
Trandolapril—Vertigo—Doxorubicin—lung cancer	0.000115	0.000256	CcSEcCtD
Trandolapril—Anorexia—Methotrexate—lung cancer	0.000115	0.000256	CcSEcCtD
Trandolapril—Syncope—Doxorubicin—lung cancer	0.000115	0.000256	CcSEcCtD
Trandolapril—Leukopenia—Doxorubicin—lung cancer	0.000115	0.000255	CcSEcCtD
Trandolapril—Diarrhoea—Docetaxel—lung cancer	0.000115	0.000255	CcSEcCtD
Trandolapril—Palpitations—Doxorubicin—lung cancer	0.000113	0.000252	CcSEcCtD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—ALB—lung cancer	0.000113	0.00174	CbGpPWpGaD
Trandolapril—Hypotension—Methotrexate—lung cancer	0.000113	0.000251	CcSEcCtD
Trandolapril—Loss of consciousness—Doxorubicin—lung cancer	0.000113	0.000251	CcSEcCtD
Trandolapril—Cough—Doxorubicin—lung cancer	0.000112	0.000249	CcSEcCtD
Trandolapril—Dizziness—Docetaxel—lung cancer	0.000111	0.000247	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—MMP1—lung cancer	0.000111	0.0017	CbGpPWpGaD
Trandolapril—Musculoskeletal discomfort—Methotrexate—lung cancer	0.00011	0.000245	CcSEcCtD
Trandolapril—Insomnia—Methotrexate—lung cancer	0.000109	0.000243	CcSEcCtD
Trandolapril—Myalgia—Doxorubicin—lung cancer	0.000109	0.000243	CcSEcCtD
Trandolapril—Chest pain—Doxorubicin—lung cancer	0.000109	0.000243	CcSEcCtD
Trandolapril—Arthralgia—Doxorubicin—lung cancer	0.000109	0.000243	CcSEcCtD
Trandolapril—Anxiety—Doxorubicin—lung cancer	0.000109	0.000242	CcSEcCtD
Trandolapril—Paraesthesia—Methotrexate—lung cancer	0.000109	0.000241	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000109	0.000241	CcSEcCtD
Trandolapril—Discomfort—Doxorubicin—lung cancer	0.000108	0.00024	CcSEcCtD
Trandolapril—Dyspnoea—Methotrexate—lung cancer	0.000108	0.00024	CcSEcCtD
Trandolapril—Somnolence—Methotrexate—lung cancer	0.000108	0.000239	CcSEcCtD
Trandolapril—Dry mouth—Doxorubicin—lung cancer	0.000107	0.000237	CcSEcCtD
Trandolapril—Vomiting—Docetaxel—lung cancer	0.000107	0.000237	CcSEcCtD
Trandolapril—Dyspepsia—Methotrexate—lung cancer	0.000107	0.000237	CcSEcCtD
Trandolapril—Rash—Docetaxel—lung cancer	0.000106	0.000235	CcSEcCtD
Trandolapril—Dermatitis—Docetaxel—lung cancer	0.000106	0.000235	CcSEcCtD
Trandolapril—Decreased appetite—Methotrexate—lung cancer	0.000105	0.000234	CcSEcCtD
Trandolapril—Headache—Docetaxel—lung cancer	0.000105	0.000234	CcSEcCtD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—ALB—lung cancer	0.000105	0.00161	CbGpPWpGaD
Trandolapril—Oedema—Doxorubicin—lung cancer	0.000105	0.000233	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Methotrexate—lung cancer	0.000105	0.000232	CcSEcCtD
Trandolapril—Fatigue—Methotrexate—lung cancer	0.000104	0.000232	CcSEcCtD
Trandolapril—Infection—Doxorubicin—lung cancer	0.000104	0.000231	CcSEcCtD
Trandolapril—Shock—Doxorubicin—lung cancer	0.000103	0.000229	CcSEcCtD
Trandolapril—Nervous system disorder—Doxorubicin—lung cancer	0.000103	0.000228	CcSEcCtD
Trandolapril—Thrombocytopenia—Doxorubicin—lung cancer	0.000103	0.000228	CcSEcCtD
Trandolapril—Tachycardia—Doxorubicin—lung cancer	0.000102	0.000227	CcSEcCtD
Trandolapril—Skin disorder—Doxorubicin—lung cancer	0.000102	0.000226	CcSEcCtD
Trandolapril—Hyperhidrosis—Doxorubicin—lung cancer	0.000101	0.000225	CcSEcCtD
Trandolapril—Anorexia—Doxorubicin—lung cancer	9.99e-05	0.000222	CcSEcCtD
Trandolapril—Nausea—Docetaxel—lung cancer	9.98e-05	0.000221	CcSEcCtD
Trandolapril—Feeling abnormal—Methotrexate—lung cancer	9.98e-05	0.000221	CcSEcCtD
Trandolapril—Gastrointestinal pain—Methotrexate—lung cancer	9.9e-05	0.00022	CcSEcCtD
Trandolapril—Hypotension—Doxorubicin—lung cancer	9.79e-05	0.000217	CcSEcCtD
Trandolapril—Urticaria—Methotrexate—lung cancer	9.62e-05	0.000213	CcSEcCtD
Trandolapril—Abdominal pain—Methotrexate—lung cancer	9.57e-05	0.000212	CcSEcCtD
Trandolapril—Body temperature increased—Methotrexate—lung cancer	9.57e-05	0.000212	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Doxorubicin—lung cancer	9.55e-05	0.000212	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—AVP—lung cancer	9.5e-05	0.00146	CbGpPWpGaD
Trandolapril—Insomnia—Doxorubicin—lung cancer	9.48e-05	0.00021	CcSEcCtD
Trandolapril—Paraesthesia—Doxorubicin—lung cancer	9.41e-05	0.000209	CcSEcCtD
Trandolapril—Dyspnoea—Doxorubicin—lung cancer	9.35e-05	0.000207	CcSEcCtD
Trandolapril—Somnolence—Doxorubicin—lung cancer	9.32e-05	0.000207	CcSEcCtD
Trandolapril—Dyspepsia—Doxorubicin—lung cancer	9.23e-05	0.000205	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ABCB1—lung cancer	9.2e-05	0.00141	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—POMC—lung cancer	9.19e-05	0.00141	CbGpPWpGaD
Trandolapril—Decreased appetite—Doxorubicin—lung cancer	9.11e-05	0.000202	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Doxorubicin—lung cancer	9.05e-05	0.000201	CcSEcCtD
Trandolapril—Fatigue—Doxorubicin—lung cancer	9.04e-05	0.000201	CcSEcCtD
Trandolapril—Constipation—Doxorubicin—lung cancer	8.96e-05	0.000199	CcSEcCtD
Trandolapril—Hypersensitivity—Methotrexate—lung cancer	8.92e-05	0.000198	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—AVP—lung cancer	8.81e-05	0.00135	CbGpPWpGaD
Trandolapril—Asthenia—Methotrexate—lung cancer	8.69e-05	0.000193	CcSEcCtD
Trandolapril—Feeling abnormal—Doxorubicin—lung cancer	8.64e-05	0.000192	CcSEcCtD
Trandolapril—Gastrointestinal pain—Doxorubicin—lung cancer	8.57e-05	0.00019	CcSEcCtD
Trandolapril—Pruritus—Methotrexate—lung cancer	8.56e-05	0.00019	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—MMP2—lung cancer	8.55e-05	0.00131	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ABCB1—lung cancer	8.54e-05	0.00131	CbGpPWpGaD
Trandolapril—Urticaria—Doxorubicin—lung cancer	8.33e-05	0.000185	CcSEcCtD
Trandolapril—Abdominal pain—Doxorubicin—lung cancer	8.29e-05	0.000184	CcSEcCtD
Trandolapril—Body temperature increased—Doxorubicin—lung cancer	8.29e-05	0.000184	CcSEcCtD
Trandolapril—Diarrhoea—Methotrexate—lung cancer	8.28e-05	0.000184	CcSEcCtD
Trandolapril—Dizziness—Methotrexate—lung cancer	8e-05	0.000178	CcSEcCtD
Trandolapril—Hypersensitivity—Doxorubicin—lung cancer	7.72e-05	0.000171	CcSEcCtD
Trandolapril—Vomiting—Methotrexate—lung cancer	7.7e-05	0.000171	CcSEcCtD
Trandolapril—Rash—Methotrexate—lung cancer	7.63e-05	0.000169	CcSEcCtD
Trandolapril—Dermatitis—Methotrexate—lung cancer	7.63e-05	0.000169	CcSEcCtD
Trandolapril—Headache—Methotrexate—lung cancer	7.58e-05	0.000168	CcSEcCtD
Trandolapril—Asthenia—Doxorubicin—lung cancer	7.52e-05	0.000167	CcSEcCtD
Trandolapril—Pruritus—Doxorubicin—lung cancer	7.42e-05	0.000165	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—APOA1—lung cancer	7.26e-05	0.00112	CbGpPWpGaD
Trandolapril—Nausea—Methotrexate—lung cancer	7.19e-05	0.00016	CcSEcCtD
Trandolapril—Diarrhoea—Doxorubicin—lung cancer	7.17e-05	0.000159	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—CXCL8—lung cancer	7.11e-05	0.00109	CbGpPWpGaD
Trandolapril—Dizziness—Doxorubicin—lung cancer	6.93e-05	0.000154	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—APOA1—lung cancer	6.74e-05	0.00104	CbGpPWpGaD
Trandolapril—Vomiting—Doxorubicin—lung cancer	6.66e-05	0.000148	CcSEcCtD
Trandolapril—Rash—Doxorubicin—lung cancer	6.61e-05	0.000147	CcSEcCtD
Trandolapril—Dermatitis—Doxorubicin—lung cancer	6.6e-05	0.000147	CcSEcCtD
Trandolapril—Headache—Doxorubicin—lung cancer	6.57e-05	0.000146	CcSEcCtD
Trandolapril—Nausea—Doxorubicin—lung cancer	6.23e-05	0.000138	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—CREBBP—lung cancer	6.15e-05	0.000945	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ALB—lung cancer	5.75e-05	0.000884	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—CREBBP—lung cancer	5.7e-05	0.000877	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ALB—lung cancer	5.34e-05	0.00082	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—RAF1—lung cancer	5.2e-05	0.0008	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—RAF1—lung cancer	4.83e-05	0.000742	CbGpPWpGaD
